$2.28T
Total marketcap
$126.02B
Total volume
BTC 49.82%     ETH 15.76%
Dominance

Willow Biosciences CANSF Stock

0.07 USD {{ price }} 2.314808% {{change_pct}}%
Exchange
Other OTC
Market Cap
8.42M USD
LOW - HIGH [24H]
0.07 - 0.07 USD
VOLUME [24H]
1.07K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.07 USD

Willow Biosciences Price Chart

Willow Biosciences CANSF Financial and Trading Overview

Willow Biosciences stock price 0.07 USD
Previous Close 0.09 USD
Open 0.09 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.09 - 0.1 USD
52 Week Range 0.06 - 0.14 USD
Volume 80.62K USD
Avg. Volume 24.47K USD
Market Cap 12.11M USD
Beta (5Y Monthly) 1.100545
PE Ratio (TTM) N/A
EPS (TTM) -0.07 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 2 USD

CANSF Valuation Measures

Enterprise Value 1.13M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 11.0621805
Price/Book (mrq) 0.96842104
Enterprise Value/Revenue 1.028
Enterprise Value/EBITDA -0.066

Trading Information

Willow Biosciences Stock Price History

Beta (5Y Monthly) 1.100545
52-Week Change -33.33%
S&P500 52-Week Change 20.43%
52 Week High 0.14 USD
52 Week Low 0.06 USD
50-Day Moving Average 0.09 USD
200-Day Moving Average 0.09 USD

CANSF Share Statistics

Avg. Volume (3 month) 24.47K USD
Avg. Daily Volume (10-Days) 31.59K USD
Shares Outstanding 124.22M
Float 88.45M
Short Ratio N/A
% Held by Insiders 27.89%
% Held by Institutions 0.12%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:25

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -1680.36%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -52.47%
Return on Equity (ttm) -85.26%

Income Statement

Revenue (ttm) 1.1M USD
Revenue Per Share (ttm) 0.009 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 821K USD
EBITDA -16968000 USD
Net Income Avi to Common (ttm) -16615000 USD
Diluted EPS (ttm) -0.11
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 10.81M USD
Total Cash Per Share (mrq) 0.09 USD
Total Debt (mrq) 507K USD
Total Debt/Equity (mrq) 4.31 USD
Current Ratio (mrq) 6.708
Book Value Per Share (mrq) 0.095

Cash Flow Statement

Operating Cash Flow (ttm) -14624000 USD
Levered Free Cash Flow (ttm) -8404250 USD

Profile of Willow Biosciences

Country United States
State AB
City Calgary
Address 202, 1201-5th Street SW
ZIP T2R 0Y6
Phone 403 910 5140
Website https://www.willowbio.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 32

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. is headquartered in Calgary, Canada.

Q&A For Willow Biosciences Stock

What is a current CANSF stock price?

Willow Biosciences CANSF stock price today per share is 0.07 USD.

How to purchase Willow Biosciences stock?

You can buy CANSF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Willow Biosciences?

The stock symbol or ticker of Willow Biosciences is CANSF.

Which industry does the Willow Biosciences company belong to?

The Willow Biosciences industry is Drug Manufacturers-Specialty & Generic.

How many shares does Willow Biosciences have in circulation?

The max supply of Willow Biosciences shares is 126.96M.

What is Willow Biosciences Price to Earnings Ratio (PE Ratio)?

Willow Biosciences PE Ratio is now.

What was Willow Biosciences earnings per share over the trailing 12 months (TTM)?

Willow Biosciences EPS is -0.07 USD over the trailing 12 months.

Which sector does the Willow Biosciences company belong to?

The Willow Biosciences sector is Healthcare.